img

Global Anti-Neprilysin Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anti-Neprilysin Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Neprilysin is a neutral endopeptidase and its inhibition increases bioavailability of natriuretic peptides, bradykinin, and substance P, resulting in natriuretic, vasodilatatory, and anti-proliferative effects.
Anti-Neprilysin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anti-Neprilysin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Anti-Neprilysin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Anti-Neprilysin key companies include Bioprojet SCR, Novartis International AG, Pharmaleads SA, Theravance Biopharma Inc., Cipla Limited and Oceanic Pharmachem Pvt. Ltd, etc. Bioprojet SCR, Novartis International AG, Pharmaleads SA are top 3 players and held % share in total in 2022.
Anti-Neprilysin can be divided into Sacubitril, TD-0714, STR-324 and PL-265, etc. Sacubitril is the mainstream product in the market, accounting for % share globally in 2022.
Anti-Neprilysin is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Anti-Neprilysin industry development. In 2022, global % share of Anti-Neprilysin went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-Neprilysin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Bioprojet SCR
Novartis International AG
Pharmaleads SA
Theravance Biopharma Inc.
Cipla Limited
Oceanic Pharmachem Pvt. Ltd
Segment by Type
Sacubitril
TD-0714
STR-324
PL-265
LHW-090

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Anti-Neprilysin market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Anti-Neprilysin introduction, etc. Anti-Neprilysin Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Anti-Neprilysin market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Anti-Neprilysin
1.1 Anti-Neprilysin Market Overview
1.1.1 Anti-Neprilysin Product Scope
1.1.2 Anti-Neprilysin Market Status and Outlook
1.2 Global Anti-Neprilysin Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Anti-Neprilysin Market Size by Region (2024-2034)
1.4 Global Anti-Neprilysin Historic Market Size by Region (2024-2024)
1.5 Global Anti-Neprilysin Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Anti-Neprilysin Market Size (2024-2034)
1.6.1 North America Anti-Neprilysin Market Size (2024-2034)
1.6.2 Europe Anti-Neprilysin Market Size (2024-2034)
1.6.3 Asia-Pacific Anti-Neprilysin Market Size (2024-2034)
1.6.4 Latin America Anti-Neprilysin Market Size (2024-2034)
1.6.5 Middle East & Africa Anti-Neprilysin Market Size (2024-2034)
2 Anti-Neprilysin Market by Type
2.1 Introduction
2.1.1 Sacubitril
2.1.2 TD-0714
2.1.3 STR-324
2.1.4 PL-265
2.1.5 LHW-090
2.2 Global Anti-Neprilysin Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Anti-Neprilysin Historic Market Size by Type (2024-2024)
2.2.2 Global Anti-Neprilysin Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Anti-Neprilysin Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Anti-Neprilysin Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Anti-Neprilysin Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Anti-Neprilysin Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Anti-Neprilysin Revenue Breakdown by Type (2024-2034)
3 Anti-Neprilysin Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Anti-Neprilysin Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Anti-Neprilysin Historic Market Size by Application (2024-2024)
3.2.2 Global Anti-Neprilysin Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Anti-Neprilysin Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Anti-Neprilysin Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Anti-Neprilysin Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Anti-Neprilysin Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Anti-Neprilysin Revenue Breakdown by Application (2024-2034)
4 Anti-Neprilysin Competition Analysis by Players
4.1 Global Anti-Neprilysin Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Neprilysin as of 2022)
4.3 Date of Key Players Enter into Anti-Neprilysin Market
4.4 Global Top Players Anti-Neprilysin Headquarters and Area Served
4.5 Key Players Anti-Neprilysin Product Solution and Service
4.6 Competitive Status
4.6.1 Anti-Neprilysin Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bioprojet SCR
5.1.1 Bioprojet SCR Profile
5.1.2 Bioprojet SCR Main Business
5.1.3 Bioprojet SCR Anti-Neprilysin Products, Services and Solutions
5.1.4 Bioprojet SCR Anti-Neprilysin Revenue (US$ Million) & (2024-2024)
5.1.5 Bioprojet SCR Recent Developments
5.2 Novartis International AG
5.2.1 Novartis International AG Profile
5.2.2 Novartis International AG Main Business
5.2.3 Novartis International AG Anti-Neprilysin Products, Services and Solutions
5.2.4 Novartis International AG Anti-Neprilysin Revenue (US$ Million) & (2024-2024)
5.2.5 Novartis International AG Recent Developments
5.3 Pharmaleads SA
5.3.1 Pharmaleads SA Profile
5.3.2 Pharmaleads SA Main Business
5.3.3 Pharmaleads SA Anti-Neprilysin Products, Services and Solutions
5.3.4 Pharmaleads SA Anti-Neprilysin Revenue (US$ Million) & (2024-2024)
5.3.5 Theravance Biopharma Inc. Recent Developments
5.4 Theravance Biopharma Inc.
5.4.1 Theravance Biopharma Inc. Profile
5.4.2 Theravance Biopharma Inc. Main Business
5.4.3 Theravance Biopharma Inc. Anti-Neprilysin Products, Services and Solutions
5.4.4 Theravance Biopharma Inc. Anti-Neprilysin Revenue (US$ Million) & (2024-2024)
5.4.5 Theravance Biopharma Inc. Recent Developments
5.5 Cipla Limited
5.5.1 Cipla Limited Profile
5.5.2 Cipla Limited Main Business
5.5.3 Cipla Limited Anti-Neprilysin Products, Services and Solutions
5.5.4 Cipla Limited Anti-Neprilysin Revenue (US$ Million) & (2024-2024)
5.5.5 Cipla Limited Recent Developments
5.6 Oceanic Pharmachem Pvt. Ltd
5.6.1 Oceanic Pharmachem Pvt. Ltd Profile
5.6.2 Oceanic Pharmachem Pvt. Ltd Main Business
5.6.3 Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Products, Services and Solutions
5.6.4 Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Revenue (US$ Million) & (2024-2024)
5.6.5 Oceanic Pharmachem Pvt. Ltd Recent Developments
6 North America
6.1 North America Anti-Neprilysin Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Anti-Neprilysin Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Anti-Neprilysin Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Anti-Neprilysin Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Anti-Neprilysin Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Anti-Neprilysin Market Dynamics
11.1 Anti-Neprilysin Industry Trends
11.2 Anti-Neprilysin Market Drivers
11.3 Anti-Neprilysin Market Challenges
11.4 Anti-Neprilysin Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Anti-Neprilysin Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Anti-Neprilysin Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Anti-Neprilysin Market Size Share by Region (2024-2024)
Table 4. Global Anti-Neprilysin Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Anti-Neprilysin Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Anti-Neprilysin Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Anti-Neprilysin Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Anti-Neprilysin Revenue Market Share by Type (2024-2024)
Table 9. Global Anti-Neprilysin Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Anti-Neprilysin Revenue Market Share by Type (2024-2034)
Table 11. North America Anti-Neprilysin Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Anti-Neprilysin Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Anti-Neprilysin Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Anti-Neprilysin Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Anti-Neprilysin Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Anti-Neprilysin Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Anti-Neprilysin Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Anti-Neprilysin Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Anti-Neprilysin Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Anti-Neprilysin Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Anti-Neprilysin Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Anti-Neprilysin Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Anti-Neprilysin Revenue Market Share by Application (2024-2024)
Table 24. Global Anti-Neprilysin Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Anti-Neprilysin Revenue Market Share by Application (2024-2034)
Table 26. North America Anti-Neprilysin Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Anti-Neprilysin Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Anti-Neprilysin Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Anti-Neprilysin Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Anti-Neprilysin Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Anti-Neprilysin Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Anti-Neprilysin Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Anti-Neprilysin Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Anti-Neprilysin Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Anti-Neprilysin Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Anti-Neprilysin Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Anti-Neprilysin Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Neprilysin as of 2022)
Table 39. Date of Key Players Enter into Anti-Neprilysin Market
Table 40. Global Anti-Neprilysin Key Players Headquarters and Area Served
Table 41. Anti-Neprilysin Product Solution and Service
Table 42. Global Anti-Neprilysin Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Bioprojet SCR Basic Information List
Table 45. Bioprojet SCR Description and Business Overview
Table 46. Bioprojet SCR Anti-Neprilysin Products, Services and Solutions
Table 47. Revenue (US$ Million) in Anti-Neprilysin Business of Bioprojet SCR (2024-2024)
Table 48. Bioprojet SCR Recent Developments
Table 49. Novartis International AG Basic Information List
Table 50. Novartis International AG Description and Business Overview
Table 51. Novartis International AG Anti-Neprilysin Products, Services and Solutions
Table 52. Revenue (US$ Million) in Anti-Neprilysin Business of Novartis International AG (2024-2024)
Table 53. Novartis International AG Recent Developments
Table 54. Pharmaleads SA Basic Information List
Table 55. Pharmaleads SA Description and Business Overview
Table 56. Pharmaleads SA Anti-Neprilysin Products, Services and Solutions
Table 57. Revenue (US$ Million) in Anti-Neprilysin Business of Pharmaleads SA (2024-2024)
Table 58. Pharmaleads SA Recent Developments
Table 59. Theravance Biopharma Inc. Basic Information List
Table 60. Theravance Biopharma Inc. Description and Business Overview
Table 61. Theravance Biopharma Inc. Anti-Neprilysin Products, Services and Solutions
Table 62. Revenue (US$ Million) in Anti-Neprilysin Business of Theravance Biopharma Inc. (2024-2024)
Table 63. Theravance Biopharma Inc. Recent Developments
Table 64. Cipla Limited Basic Information List
Table 65. Cipla Limited Description and Business Overview
Table 66. Cipla Limited Anti-Neprilysin Products, Services and Solutions
Table 67. Revenue (US$ Million) in Anti-Neprilysin Business of Cipla Limited (2024-2024)
Table 68. Cipla Limited Recent Developments
Table 69. Oceanic Pharmachem Pvt. Ltd Basic Information List
Table 70. Oceanic Pharmachem Pvt. Ltd Description and Business Overview
Table 71. Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Products, Services and Solutions
Table 72. Revenue (US$ Million) in Anti-Neprilysin Business of Oceanic Pharmachem Pvt. Ltd (2024-2024)
Table 73. Oceanic Pharmachem Pvt. Ltd Recent Developments
Table 74. North America Anti-Neprilysin Market Size by Country (2024-2024) & (US$ Million)
Table 75. North America Anti-Neprilysin Market Size by Country (2024-2034) & (US$ Million)
Table 76. Europe Anti-Neprilysin Market Size by Country (2024-2024) & (US$ Million)
Table 77. Europe Anti-Neprilysin Market Size by Country (2024-2034) & (US$ Million)
Table 78. Asia-Pacific Anti-Neprilysin Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 79. Asia-Pacific Anti-Neprilysin Market Size by Region (2024-2024) & (US$ Million)
Table 80. Asia-Pacific Anti-Neprilysin Market Size by Region (2024-2034) & (US$ Million)
Table 81. Asia-Pacific Anti-Neprilysin Market Share by Region (2024-2024)
Table 82. Asia-Pacific Anti-Neprilysin Market Share by Region (2024-2034)
Table 83. Latin America Anti-Neprilysin Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 84. Latin America Anti-Neprilysin Market Size by Country (2024-2024) & (US$ Million)
Table 85. Latin America Anti-Neprilysin Market Size by Country (2024-2034) & (US$ Million)
Table 86. Middle East & Africa Anti-Neprilysin Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 87. Middle East & Africa Anti-Neprilysin Market Size by Country (2024-2024) & (US$ Million)
Table 88. Middle East & Africa Anti-Neprilysin Market Size by Country (2024-2034) & (US$ Million)
Table 89. Anti-Neprilysin Market Trends
Table 90. Anti-Neprilysin Market Drivers
Table 91. Anti-Neprilysin Market Challenges
Table 92. Anti-Neprilysin Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Neprilysin Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Anti-Neprilysin Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Anti-Neprilysin Market Share by Regions: 2022 VS 2034
Figure 4. Global Anti-Neprilysin Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Anti-Neprilysin Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Anti-Neprilysin Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Anti-Neprilysin Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Anti-Neprilysin Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Anti-Neprilysin Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Sacubitril
Figure 11. Global Sacubitril Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of TD-0714
Figure 13. Global TD-0714 Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of STR-324
Figure 15. Global STR-324 Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of PL-265
Figure 17. Global PL-265 Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Product Picture of LHW-090
Figure 19. Global LHW-090 Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 20. Global Anti-Neprilysin Market Size Share by Type: 2022 & 2034
Figure 21. North America Anti-Neprilysin Revenue Market Share by Type (2024-2034)
Figure 22. Europe Anti-Neprilysin Revenue Market Share by Type (2024-2034)
Figure 23. Asia-Pacific Anti-Neprilysin Revenue Market Share by Type (2024-2034)
Figure 24. Latin America Anti-Neprilysin Revenue Market Share by Type (2024-2034)
Figure 25. Middle East and Africa Anti-Neprilysin Revenue Market Share by Type (2024-2034)
Figure 26. Hospital Pharmacies Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 27. Retail Pharmacies Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 28. Online Pharmacies Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 29. Global Anti-Neprilysin Market Size Share by Application: 2022 & 2034
Figure 30. North America Anti-Neprilysin Revenue Market Share by Application (2024-2034)
Figure 31. Europe Anti-Neprilysin Revenue Market Share by Application (2024-2034)
Figure 32. Asia-Pacific Anti-Neprilysin Revenue Market Share by Application (2024-2034)
Figure 33. Latin America Anti-Neprilysin Revenue Market Share by Application (2024-2034)
Figure 34. Middle East and Africa Anti-Neprilysin Revenue Market Share by Application (2024-2034)
Figure 35. Anti-Neprilysin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 36. Global Top 5 and Top 10 Players Anti-Neprilysin Market Share in 2022
Figure 37. North America Anti-Neprilysin Market Share by Country (2024-2034)
Figure 38. United States Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 39. Canada Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 40. Germany Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 41. France Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 42. U.K. Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 43. Italy Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 44. Russia Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 45. Nordic Countries Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 46. Asia-Pacific Anti-Neprilysin Market Share by Region (2024-2034)
Figure 47. China Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 48. Japan Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 49. South Korea Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 50. Southeast Asia Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 51. India Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 52. Australia Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 53. Latin America Anti-Neprilysin Market Share by Country (2024-2034)
Figure 54. Mexico Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 55. Brazil Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 56. Middle East & Africa Anti-Neprilysin Market Share by Country (2024-2034)
Figure 57. Turkey Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 58. Saudi Arabia Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 59. UAE Anti-Neprilysin Market Size (2024-2034) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report